January 14, 2025 at 01:27PM Artificial Intelligence and Machine Learning (AI/ML) for Biological and Other Products Regulated by CBER

Use of Artificial Intelligence and Machine Learning (AI/ML) has rapidly become an important component of everyday life. This includes using AI/ML in the development of Medical Products, including Biologics. This page provides an overview of CBER's activity in AI/ML.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/jUGohMT